Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bayer Inc
Scientific Title
A Randomized, Double-blind, Placebo Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients With Metastatic Hormone Sensitive Prostate Cancer